Hospitalist Daniel K. Holleran, MD, Joins Fox Chase's Department of Medicine

December 14, 2010

PHILADELPHIA (December 14, 2010) – Daniel K. Holleran, MD, Attending Physician, Hospitalist Service, Internal Medicine, has joined Fox Chase Cancer Center’s Department of Medicine as an attending physician for the hospitalist program.

“I came to Fox Chase to be part of the comprehensive treatment plan,” says Holleran, who has a special interest in medical oncology.  “I enjoy hospital medicine and feel I will add to the total care of the patient.”

His role at Fox Chase will involve coordinating care with medical, surgical and radiation oncologists, as well as handling any other medical issues that may arise for patients.

“I have over 19 years of experience in primary care, hospitalist and consultative medicine,” says Holleran, who comes to Fox Chase from Thomas Jefferson University in Philadelphia, where he served as a clinical assistant professor of medicine.

Holleran earned his MD from Hahnemann University in Philadelphia, where he also completed his residency in internal medicine.  Prior to his medical studies, Holleran pursued an MS in chemistry and worked as a research chemist in drug and vaccine formation.

Holleran is certified in internal medicine by the National Board of Medical Examiners and is a member of the American College of Physicians.



The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence five consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase